Browse by all authors Browse By Author Name - Linardopoulos,+Spiros

Browse Results (3 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Podesta, Jennifer E., Sugar, Richard, Squires, Matt, Linardopoulos, Spiros, Pearson, Andrew D. J. and Moore, Andrew S. (2011) Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia. Leukemia Research, 35 9: 1273-1275. doi:10.1016/j.leukres.2011.05.022 33   2 Cited 3 times in Scopus3 0
Bavetsias, Vassilios, Crumpler, Simon, Sun, Chongbo, Avery, Sian, Atrash, Butrus, Faisal, Amir, Moore, Andrew S., Kosmopoulou, Magda, Brown, Nathan, Sheldrake, Peter W., Bush, Katherine, Henley, Alan, Box, Gary, Valenti, Melanie, Brandon, Alexis de Haven, Raynaud, Florence I., Workman, Paul, Eccles, Suzanne A., Bayliss, Richard, Linardopoulos, Spiros and Blagg, Julian (2012) Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia. Journal of Medicinal Chemistry, 55 20: 8721-8734. doi:10.1021/jm300952s 84   13 Cited 14 times in Scopus14 1
Faisal, Amir, Vaughan, Lynsey, Bavetsias, Vassilios, Sun, Chongbo, Atrash, Butrus, Avery, Sian, Jamin, Yann, Robinson, Simon P., Workman, Paul, Blagg, Julian, Raynaud, Florence I., Eccles, Suzanne A., Chesler, Louis and Linardopoulos, Spiros (2011) The Aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. Molecular Cancer Therapeutics, 10 11: 2115-2123. doi:10.1158/1535-7163.MCT-11-0333 35   18 Cited 17 times in Scopus17 3